124 related articles for article (PubMed ID: 3466235)
1. Prostaglandin sensitivity of the PHA-response of blood lymphocytes following radiation therapy for breast cancer.
Blomgren H; Hammarström S; Wasserman J; Petrini B
Radiother Oncol; 1986 Oct; 7(2):141-5. PubMed ID: 3466235
[TBL] [Abstract][Full Text] [Related]
2. Effects of some prostaglandins and leukotrienes on lymphocytes, monocytes and their activity in vitro.
Wasserman J; Hammarström S; Petrini B; Blomgren H; von Stedingk LV; Vedin I
Int Arch Allergy Appl Immunol; 1987; 83(1):39-43. PubMed ID: 3032806
[TBL] [Abstract][Full Text] [Related]
3. Possible role of prostaglandin producing monocytes in the depression of mitogenic responses of blood lymphocytes following radiation therapy.
Blomgren H; Wasserman J; Rotstein S; Petrini B; Baral E
Radiother Oncol; 1984 Jan; 1(3):255-61. PubMed ID: 6095371
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
Balch CM; Dougherty PA; Cloud GA; Tilden AB
Surgery; 1984 Jan; 95(1):71-7. PubMed ID: 6229053
[TBL] [Abstract][Full Text] [Related]
5. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
Rocklin RE; Thistle L; Audera C
J Immunol; 1985 Sep; 135(3):2033-9. PubMed ID: 3160784
[TBL] [Abstract][Full Text] [Related]
6. Effects of indomethacin and prostaglandins E2, I2, and D2 on the fetal circulation.
Sideris EB; Yokochi K; Van Helder T; Coceani F; Olley PM
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():477-82. PubMed ID: 6221634
[No Abstract] [Full Text] [Related]
7. In vitro capacity of various cyclooxygenase inhibitors to revert immune suppression caused by radiation therapy for breast cancer.
Blomgren H; Rotstein S; Wasserman J; Petrini B; Hammarström S
Radiother Oncol; 1990 Dec; 19(4):329-35. PubMed ID: 2126634
[TBL] [Abstract][Full Text] [Related]
8. Immune dysfunction in primary biliary cirrhosis (PBC): I. Increased sensitivity of PHA stimulated lymphocyte cultures to indomethacin.
Licastro F; Lenzi M; Chiricolo M; Davis LJ; Cassani F; Bianchi F; Franceschi C
J Clin Lab Immunol; 1987 May; 23(1):19-23. PubMed ID: 3612758
[TBL] [Abstract][Full Text] [Related]
9. Actions of indomethacin and prostaglandins E2 and D2 on nerve transmission in the nictitating membrane of the cat.
Hemker DP; Aiken JW
Prostaglandins; 1981 Oct; 22(4):599-611. PubMed ID: 6275457
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of thymosin fraction 5 on proliferation of cultured human T lymphocytes.
Wolf RE; Maca RD
Immunopharmacology; 1986 Dec; 12(3):233-40. PubMed ID: 3493229
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer.
McCormick KJ; Panje WR
Cancer Immunol Immunother; 1986; 21(3):226-32. PubMed ID: 3457630
[TBL] [Abstract][Full Text] [Related]
12. The effects of indomethacin on T lymphocyte stimulation.
Kingston AE; Ivanyi J; Kay JE
Immunol Lett; 1984; 8(6):301-5. PubMed ID: 6335488
[TBL] [Abstract][Full Text] [Related]
13. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
14. Effects of prostaglandins on motility of gallbladders removed from patients with gallstones.
Kotwall CA; Clanachan AS; Baer HP; Scott GW
Arch Surg; 1984 Jun; 119(6):709-12. PubMed ID: 6732480
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human gingival carcinoma cell growth by prostaglandins.
Suzuki K; Kobayashi N; Moriya Y; Abiko Y; Suzuki H
Gen Pharmacol; 1988; 19(2):273-6. PubMed ID: 3162424
[TBL] [Abstract][Full Text] [Related]
16. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.
Wanebo HJ; Pace R; Hargett S; Katz D; Sando J
Cancer; 1986 Feb; 57(3):656-62. PubMed ID: 3484660
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of prostaglandin E2 and thromboxane A2 synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytes.
Awara W; Hillier K; Jones D
Immunology; 1986 Dec; 59(4):557-62. PubMed ID: 3468061
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 inhibits the generation of phytohemagglutinin-activated killer activity in human peripheral blood lymphocytes.
Yamashita N; Ito M; Suzuki H; Sugiyama E; Yokoyama A; Sato M; Yano S
Anticancer Res; 1986; 6(5):1113-6. PubMed ID: 3492171
[TBL] [Abstract][Full Text] [Related]
19. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression.
Tilden AB; Balch CM
Surgery; 1982 Sep; 92(3):528-32. PubMed ID: 6287658
[TBL] [Abstract][Full Text] [Related]
20. Regulation of lymphocyte activation by PGE2 in multiple sclerosis.
DuBois JH; Cuzner ML
J Neurol Sci; 1984 Aug; 65(2):211-9. PubMed ID: 6384431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
